Comparison of the Direct Oral Anticoagulants and Warfarin in Patients With Atrial Fibrillation and Valvular Heart Disease: Updated Systematic Review and Meta-Analysis of Randomized Controlled Trials

Background: Direct oral anticoagulants (DOACS) are approved for use in non-valvular atrial fibrillation (AF). This systematic review and meta-analysis aimed to evaluate the efficacy and safety of DOACs vs. warfarin and update the evidence for treatment of AF and valvular heart disease (VHD). Methods...

Descripción completa

Detalles Bibliográficos
Autores principales: Bitar, Yasmin de Souza Lima, Duraes, Andre Rodrigues, Roever, Leonardo, Gomes Neto, Mansueto, Lins-Kusterer, Liliane, Bocchi, Edimar Alcides
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Cardiovascular Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8494252/
https://www.ncbi.nlm.nih.gov/pubmed/34631818
http://dx.doi.org/10.3389/fcvm.2021.712585

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8494252/
https://www.ncbi.nlm.nih.gov/pubmed/34631818
http://dx.doi.org/10.3389/fcvm.2021.712585

Ejemplares similares